FDA is proposing to require the submission of GRAS notices for human and animal food substances. NPA is carefully monitoring these developments.

This year’s NPA Fly-In Day was a powerful reminder of why direct advocacy continues to shape the future of dietary supplements, natural products and consumer access to wellness.

AI’s most practical value in regulated manufacturing environments lies in supporting information access, regulatory context and risk-based prioritization.

Updating the definition of “essential” micronutrients may be one of the most important health reforms the Trump administration can make.

NPA board members met last week with congressional offices and White House officials to push for federal preemption, drug-preclusion reform, stable trade policies and stronger support for U.S. innovation.

Lief Labs founder and NPA board member Adel Villalobos is spearheading a campaign to raise $5 million. The “Fueling the Next 90” campaign on behalf of NPA represents a capital investment in our shared future, he writes.